RSV Immunization

Infectious Disease

11 drugs in development·2 companies·5 clinical trials

Drug Pipeline by Phase

Phase 3(5)

Drug	Company
hepatitis b vaccine	Sanofi (SNY)
measles mumps	Sanofi (SNY)
rsvt vaccine	Sanofi (SNY)
streptococcus pneumoniae vaccine	Sanofi (SNY)
varicella virus vaccine	Sanofi (SNY)

Phase 2(3)

Phase 4(3)

Drug	Company
nirsevimab	Sanofi (SNY)
nirsevimab	Sanofi (SNYNF)
nirsevimab respiratory syncytial virus monoclonal antibody	Sanofi (SNY)

BioSniper tracks 11 drugs in development for RSV Immunization across 2 companies.

There are 5 clinical trials targeting RSV Immunization tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.